Brazil’s Butantan Partners with U.S. for Zika Vaccine

By Lise Alves, Senior Contributing Reporter

SÃO PAULO, BRAZIL – The Butantan Institute in Brazil has announced a partnership with the United States’ Health Department and the World Health Organization (WHO) to expand the research capacity of its laboratories and increase Brazil’s capacity to produce a Zika vaccine. According to the Brazilian institute it will receive US$3 million to research a Zika vaccine with inactivated virus.

"The investment recognizes the excellence of the Butantan Institute in the research and production of new biopharmaceuticals. The partnership will allow the institution to continue the production of a vaccine against the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?